Exact Mass: 356.1362
Exact Mass Matches: 356.1362
Found 140 metabolites which its exact mass value is equals to given mass value 356.1362,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-O-Methylgalactinol
4-O-Methylgalactinol is found in pulses. 4-O-Methylgalactinol is a constituent of the seeds of azuki bean (Vigna angularis). Constituent of the seeds of azuki bean (Vigna angularis). 4-O-Methylgalactinol is found in pulses.
Galactopinitol B
Galactopinitol B is found in pulses. Galactopinitol B is a constituent of soya beans. Constituent of soya beans. Galactopinitol B is found in soy bean and pulses.
Galactopinitol A
Galactopinitol a is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Galactopinitol a is soluble (in water) and a very weakly acidic compound (based on its pKa). Galactopinitol a can be found in pulses and soy bean, which makes galactopinitol a a potential biomarker for the consumption of these food products. Galactopinitol A is found in pulses. Galactopinitol A is a constituent of soya bean seeds and numerous other plant species in the Leguminosae.
D-Pinitol 2-O-alpha-D-Galactopyranosyl
D-Pinitol 2-O-alpha-D-Galactopyranosyl is found in pulses. D-Pinitol 2-O-alpha-D-Galactopyranosyl is a constituent of soya beans. Constituent of soya beans. D-Pinitol 2-O-alpha-D-Galactopyranosyl is found in pulses.
N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N'-[4-(dimethylamino)phenyl]urea
Gentiobioside
methiothepin
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
Alinamin
4-O-beta-D-Galaktopyranosyl-2-O-methyl-D-galaktose
Me glycoside-beta-Furanose2-O-beta-D-Galactofuranosyl-D-galactose
Me glycoside-alpha-Pyranose-3-O-alpha-D-Galactopyranosyl-D-galactose
Methyl 6-O-(a-D-mannopyranosyl)-a-D-mannopyranoside
ethane-1,2-diol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|Ethane-1,2-diol 1-O-??-D-apiofuranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
1-Methyl-1,4-[(1H-indole-2,3-diyl)methylene]-1,4-dihydro-2H-pyrazino[2,1-b]quinazoline-3,6-dione
Me glycoside-beta-Furanose-3-O-beta-D-Galactofuranosyl-D-galactose
Me glycoside-alpha-Pyranose6-O-beta-D-Galactopyranosyl-D-mannose
Me glycoside-3-O-beta-D-Galactofuranosyl-D-mannose
Methyl 3-O-(a-D-mannopyranosyl)-a-D-mannopyranoside
2-(1-acetylamino-ethyl)-thiazole-4-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-amide
methiothepin
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
Gly Gly His Ser
Gly Gly Ser His
Gly His Gly Ser
Gly His Ser Gly
Gly Ser Gly His
Gly Ser His Gly
His Gly Gly Ser
His Gly Ser Gly
His Ser Gly Gly
Ser Gly Gly His
Ser Gly His Gly
Ser His Gly Gly
4-O-Methylgalactinol
Galactopinitol B
Galactopinitol A
Sodium isopropyl sulfate
[(8E)-8-[(4-aminophenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium,chloride
1-(benzenesulfonyl)-3-(4-methylpiperazin-1-yl)indazole
4-(3,4-dichloro-2-methylphenoxy)-1-(piperidin-4-ylmethyl)piperidine
METHYL 4-(4-(3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-YL)BENZOATE
2-Amino-5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-4(5H)-thiazolone
4-(2,4-Dichloro-3-Methylphenoxy)-1-piperidin-4-ylmethyl-piperidine
2,6-di-tert-butyl-4-methylpyrylium trifluoromethanesulfonate
2-[(TERT-BUTYLDIPHENYLSILYLOXY)METHYL]-1,3-DIOXOLAN-4-ONE
4-[N-[2-(ACETAMIDO)ETHYL]-N-METHYLAMINO]-2-CARBOXY-2-HYDROXYBENZOPHENONE
4-[6-amino-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
1-[6,7-dimethoxy-1-(4-nitro-phenyl)-3,4-dihydro-1h-isoquinolin-2-yl]-ethanone
(E)-3-(dimethylamino)-1-(5-methoxy-2-nitro-4-phenylmethoxyphenyl)prop-2-en-1-one
tert-Butyl 2-chloro-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
tert-Butyl 2-chloro-4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Debio-1347
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
N-cyclohexyl-2-(3-oxo-5-sulfanylidene-2,6-dihydroimidazo[1,2-c]quinazolin-2-yl)acetamide
alpha-D-Gal-(1->3)-alpha-D-Gal-OMe
A disaccharide derivative comprising methyl alpha-D-galactoside having an alpha-D-galactosyl residue at the 3-position.
alpha-D-Gal-(1->4)-alpha-D-Gal-OMe
A methyl glycoside that consists of methyl alpha-D-galactoside having an alpha-D-galactosyl residue at the 4-position.
{[2-(4-Ethoxyphenyl)-1,3-thiazol-4-yl]methyl}[2-(4-fluorophenyl)ethyl]amine
6-Amino-2-[(1-Naphthylmethyl)amino]-3,7-Dihydro-8h-Imidazo[4,5-G]quinazolin-8-One
4-[3-(1H-Benzimidazol-2-YL)-1H-indazol-6-YL]-2-methoxyphenol
2-o-(alpha-d-Galactopyranosyl)-3-o-methyl-d-chiro-inositol
2,4-Diamino-6-ethyl-5,3-(2-trifluoromethylphenoxy)prop-1-yloxypyrimidine
2-(3-nitrophenyl)-N-(phenylmethyl)-4-quinazolinamine
N-(3,4-dimethoxyphenyl)-3-(3-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxamide
6-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-quinazolinamine
Acetamide, N,N-diethyl-2-(10-oxo-1,2-dihydro-10H-3-thia-4,9,10a-triazacyclopenta[b]fluoren-9-yl)-
(2Z)-2-[(2-methoxyanilino)methylidene]-3-methyl-1-oxopyrido[1,2-a]benzimidazole-4-carbonitrile
ethyl (5E)-5-(2-anilino-4H-1,3,4-thiadiazin-5-ylidene)-2,4-dimethylpyrrole-3-carboxylate
N-[(E)-(1,3-diphenyl-1H-pyrazol-4-yl)methylidene]furan-2-carbohydrazide
2-Fluorobenzaldehyde (6-methyl-4-phenyl-2-quinazolinyl)hydrazone
N-(1,3-benzodioxol-5-ylmethyl)-6-(3-pyridinyl)-4-quinazolinamine
methyl 6-O-beta-D-galactofuranosyl-beta-D-mannopyranoside
methyl 3-O-beta-D-galactofuranosyl-beta-D-mannopyranoside
2-[(2R,5R,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2S,5S,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2S,5R,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2S,5R,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2R,5S,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2S,5S,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2R,5R,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
2-[(2R,5S,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N,N-dimethylacetamide
beta-D-Gal-(1->4)-beta-D-Glc-OMe
A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position.
beta-D-Galf-(1->6)-alpha-D-Manp-OMe
The methyl glycoside of the disaccharide beta-D-galactofuranosyl-(1->6)-alpha-D-mannose.
beta-D-Galf-(1->3)-alpha-D-Manp-OMe
The methyl glycoside of the disaccharide beta-D-galactofuranosyl-(1->3)-alpha-D-mannose.
(Rac)-PF-06256142
(Rac)-PF-06256142 is the less effective enantiomer of PF-06256142 (HY-119943). (Rac)-PF-06256142 is an agonist of D1 receptor, with an EC50 of 107 nM. (Rac)-PF-06256142 can be used for the research of schizophrenia and Parkinson's disease[1].
PF-06256142
PF-06256142 is a potent, selective, CNS-penetrant and orally active agonist of the D1 receptor, with an EC50 and Ki of 33 nM and 12 nM, respectively. PF-06256142 has the potential for the research of schizophrenia and Parkinson's disease[1].
